Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Blood (2018) 132 (Supplement 1): 2527.

https://doi.org/10.1182/blood-2018-99-113589

Published: 2018

Journal Articles

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Gary E. Raskob, PhD, Nick Van Es, MD, Peter Verhamme, MD PhD, Marc Carrier, MD, Marcello Di Nisio, MD, David A. Garcia, MD, Michael A. Grosso, MD, Ajay K. Kakkar, MBBS, Michael J. Kovacs, MD, Michele F. Mercuri, MD PhD FAHA, Guy Meyer, MD, Annelise Segers, MD, Minggao Shi, PhD, Tzu-Fei Wang, MD, Erik Yeo, MD FACP, FRCPC, George Zhang, PhD, Jeffrey I. Zwicker, MD, Jeffrey I. Weitz, MD, Harry R. Büller, MD PhD

Blood (2017) 130 (Supplement 1): LBA-6.

https://doi.org/10.1182/blood.V130.Suppl_1.LBA-6.LBA-6

Published: 2017

Journal Articles

The Performance of the Original and Simplified Wells Scores in Combination with Age-Adjusted D-Dimer Testing in the Diagnostic Management of Pulmonary Embolism

Noémie Kraaijpoel, MSc, Nick van Es, MD, Harry R Büller, MD PhD, Frederikus A Klok, MD PhD, Menno V Huisman, Paul L den Exter, MD PhD, Javier Galipienzo, MD PhD, Saskia Middeldorp, MD PhD, Patrick M Bossuyt, PhD

Blood (2016) 128 (22): 2569.

https://doi.org/10.1182/blood.V128.22.2569.2569

Published: 2016

Journal Articles

Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients

Noémie Kraaijpoel, MSc, Nick van Es, MD, Suzanne M Bleker, MD, Marjolein P Brekelmans, MD, Elise S Eerenberg, MD, Saskia Middeldorp, MD PhD Professor of MDcine, Alexander T Cohen, MBBS MSc MD, Harry R Büller, MD PhD

Blood (2016) 128 (22): 2611.

https://doi.org/10.1182/blood.V128.22.2611.2611

Published: 2016

Journal Articles

A New Microparticle Coagulant Activity Assay to Predict Venous Thromboembolism in Patients with Pancreatic Cancer

Nick van Es, MD, Suzanne Bleker, MD, Ankie Kleinjan, MDPhD, Rene Berckmans, PhD, J W Wilmink, MDPhD, Rienk Nieuwland, PhD, Saskia Middeldorp, MD PhD, Harry R Büller, MD PhD

Blood (2014) 124 (21): 4250.

https://doi.org/10.1182/blood.V124.21.4250.4250

Published: 2014

Journal Articles

Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data

Alexander Cohen, MD, Alexander S. Gallus, MD, Giancarlo Agnelli, MD, Harry R Buller, MD PhD, Raphael Pak, PhD, Anthony R. Porcari, PhD PharmD, Gary E. Raskob, PhD, Jeffrey I. Weitz, MDFRCPC, Takaharu Yamabe, PhD

Blood (2014) 124 (21): 1543.

https://doi.org/10.1182/blood.V124.21.1543.1543

Published: 2014

Journal Articles

Unsuspected Pulmonary Embolism in Cancer Patients: A Multicenter, International, Prospective, Observational Study

Suzanne Bleker, MD, Nick van Es, MD, Ankie Kleinjan, MD PhD, Harry R. Büller, MD PhD, Saskia Middeldorp, MD PhD, Marcello Dinisio, MD PhD

Blood (2014) 124 (21): 1546.

https://doi.org/10.1182/blood.V124.21.1546.1546

Published: 2014

Journal Articles

Aspirin and Aspirin Combined with Low-Molecular-Weight Heparin in Women with Unexplained Recurrent Miscarriage: a Randomized Controlled Multicenter Trial (ALIFE Study).

Stef P. Kaandorp, MD, Mariëtte Goddijn, MD, PhD, Joris A.M. van der Post, MD, PhD, Barbara A. Hutten, PhD, Harold R. Verhoeve, MD, Karly Hamulyak, MD, PhD, Ben-Willem Mol, MD, PhD, Nienke Folkeringa, MD, PhD, Marleen Nahuis, MD, Dimitri Papatsonis, MD, PhD, Harry R. Buller, MD, PhD, Fulco van der Veen, MD, PhD, Saskia Middeldorp, MD, PhD

Blood (2009) 114 (22): 488.

https://doi.org/10.1182/blood.V114.22.488.488

Published: 2009

Journal Articles

Hyperthyroidism as a Risk Factor for Venous Thromboembolism: A Case-Control Study

Bregje van Zaane, MD, Alessandro Squizzato, MD, Roeland Huijgen, MD, Anton P van Zanten, Eric Fliers, MD, PhD, Harry R Buller, MD, PhD, Victor E.A. Gerdes, MD, PhD, Dees P.M. Brandjes, MD, PhD

Blood (2008) 112 (11): 5350.

https://doi.org/10.1182/blood.V112.11.5350.5350

Published: 2008

Journal Articles

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Willem M. Lijfering, MD, Michiel Coppens, MD, Nic J.G.M. Veeger, MSc, Saskia Middeldorp, MD, PhD, Karly Hamulyak, MD, PhD, Martin H. Prins, MD, Phd, Harry R. Buller, MD, PhD, Jan van der Meer, Md, PhD

Blood (2007) 110 (11): 130.

https://doi.org/10.1182/blood.V110.11.130.130

Published: 2007

Journal Articles

Once Weekly Subcutaneous Idraparinux Versus Placebo in the Extended Treatment of Deep-Vein Thrombosis or Pulmonary Embolism. The van Gogh Investigators.

Harry R. Buller, MD, on Behalf of the Van Gogh Investigators

Blood (2006) 108 (11): 571.

https://doi.org/10.1182/blood.V108.11.571.571

Published: 2006

Journal Articles

Evaluation of Once Weekly Subcutaneous Idraparinux Versus Standard Therapy with Heparin and Vitamin K Antagonists in the Treatment of Deep-Vein Thrombosis or Pulmonary Embolism - The Van Gogh Investigators.

Harry R. Buller, MD, on Behalf of the Van Gogh Investigators

Blood (2006) 108 (11): 6.

https://doi.org/10.1182/blood.V108.11.6.6

Published: 2006

Journal Articles

Initial Outpatient Treatment of Venous Thromboembolism with Fondaparinux (Arixtra®): The Matisse Trials.

Harry R. Buller, MD, the MATISSE Investigators

Blood (2004) 104 (11): 705.

https://doi.org/10.1182/blood.V104.11.705.705

Published: 2004

Journal Articles

Efficacy and Safety of Fondaparinux (ARIXTRA®) in the Initial Treatment of Venous Thromboembolism in Obese Patients.

Harry R. Buller, MD, the MATISSE Investigators

Blood (2004) 104 (11): 706.

https://doi.org/10.1182/blood.V104.11.706.706

Published: 2004

NARROW

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

The Performance of the Original and Simplified Wells Scores in Combination with Age-Adjusted D-Dimer Testing in the Diagnostic Management of Pulmonary Embolism

Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients

A New Microparticle Coagulant Activity Assay to Predict Venous Thromboembolism in Patients with Pancreatic Cancer

Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data

Unsuspected Pulmonary Embolism in Cancer Patients: A Multicenter, International, Prospective, Observational Study

Aspirin and Aspirin Combined with Low-Molecular-Weight Heparin in Women with Unexplained Recurrent Miscarriage: a Randomized Controlled Multicenter Trial (ALIFE Study).

Hyperthyroidism as a Risk Factor for Venous Thromboembolism: A Case-Control Study

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Once Weekly Subcutaneous Idraparinux Versus Placebo in the Extended Treatment of Deep-Vein Thrombosis or Pulmonary Embolism. The van Gogh Investigators.

Evaluation of Once Weekly Subcutaneous Idraparinux Versus Standard Therapy with Heparin and Vitamin K Antagonists in the Treatment of Deep-Vein Thrombosis or Pulmonary Embolism - The Van Gogh Investigators.

Initial Outpatient Treatment of Venous Thromboembolism with Fondaparinux (Arixtra®): The Matisse Trials.

Efficacy and Safety of Fondaparinux (ARIXTRA®) in the Initial Treatment of Venous Thromboembolism in Obese Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only